Actively Recruiting
Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
Led by University Hospital Marburg · Updated on 2025-02-20
1000
Participants Needed
1
Research Sites
1065 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The present study is a prospective study on the development of seizure frequency, medication adherence, quality of life and cognitive performance after a first epileptic seizure using the new diagnostic criteria for epilepsy of the International League Against Epilepsy of 2014 at the time of diagnosis.
CONDITIONS
Official Title
Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Completion of the 18th year of life
- First epileptic seizure
- Ability to understand the patient information and to give written consent
- Written consent for voluntary participation in the study
You will not qualify if you...
- Chronic drug or alcohol abuse in the last two years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
c/o Klinik für Neurologie
Marburg, Hesse, Germany, 35043
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here